EP0851771A2 - Agents de formation de chelates de nicotinamide bifonctionnels du type n2s2 pour isotopes radioactifs - Google Patents
Agents de formation de chelates de nicotinamide bifonctionnels du type n2s2 pour isotopes radioactifsInfo
- Publication number
- EP0851771A2 EP0851771A2 EP96944563A EP96944563A EP0851771A2 EP 0851771 A2 EP0851771 A2 EP 0851771A2 EP 96944563 A EP96944563 A EP 96944563A EP 96944563 A EP96944563 A EP 96944563A EP 0851771 A2 EP0851771 A2 EP 0851771A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- ile
- asp
- cys
- leu
- phe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/081—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
L'invention concerne de nouveaux composés de formule générale (I), où M représente un radio-isotope de Tc ou Re, et L représente un ligand de formule générale (II) dans laquelle R?1, R2, R3, R4, R5 et R6¿ peuvent avoir différentes significations et représenter des groupes qui sont appropriés pour la liaison de coopération d'ions métalliques et le couplage à des composés à enrichissement sélectif. Ces nouveaux composés servent à la formation de complexes de technétium et de rhénium, et peuvent être utilisés en médecine pour des applications diagnostiques et thérapeutiques.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1995136783 DE19536783A1 (de) | 1995-09-21 | 1995-09-21 | Bifunktionelle Nicotinamid-Chelatbildner vom Typ N¶2¶S¶2¶ für radioaktive Isotope |
DE19536783 | 1995-09-21 | ||
PCT/DE1996/001824 WO1997010853A2 (fr) | 1995-09-21 | 1996-09-19 | Agents de formation de chelates de nicotinamide bifonctionnels du type n2s2 pour isotopes radioactifs |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0851771A2 true EP0851771A2 (fr) | 1998-07-08 |
Family
ID=7773890
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96944563A Withdrawn EP0851771A2 (fr) | 1995-09-21 | 1996-09-19 | Agents de formation de chelates de nicotinamide bifonctionnels du type n2s2 pour isotopes radioactifs |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0851771A2 (fr) |
AU (1) | AU1300597A (fr) |
CA (1) | CA2232340A1 (fr) |
DE (1) | DE19536783A1 (fr) |
WO (1) | WO1997010853A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19652374A1 (de) * | 1996-12-04 | 1998-06-10 | Schering Ag | Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung |
US7060251B1 (en) | 1997-09-08 | 2006-06-13 | The General Hospital Corporation | Imaging agents for early detection and monitoring of cardiovascular plaque |
AU9307498A (en) * | 1997-09-08 | 1999-03-29 | General Hospital Corporation, The | Imaging agents for early detection and monitoring of cardiovascular plaque |
US6388062B1 (en) | 1998-05-08 | 2002-05-14 | The Wistar Institute Of Anatomy And Biology | Modified p53 tetramerization domains having hydrophobic amino acid substitutions |
AU3875400A (en) * | 1999-03-12 | 2000-09-28 | Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The | Hydrazide inhibitors of hiv-1 integrase |
WO2003000657A1 (fr) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
WO2003016302A1 (fr) | 2001-08-09 | 2003-02-27 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
WO2003000680A1 (fr) * | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
JP4630267B2 (ja) * | 2002-12-25 | 2011-02-09 | 第一三共株式会社 | ジアミン誘導体 |
CA2511493A1 (fr) * | 2002-12-25 | 2004-07-15 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
CN1751025B (zh) * | 2002-12-25 | 2010-05-12 | 第一制药株式会社 | 二胺衍生物 |
JP2007510643A (ja) * | 2003-11-06 | 2007-04-26 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 医薬化合物 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69023394T2 (de) * | 1989-06-16 | 1996-07-04 | Merck Frosst Canada Inc | Chelat-Derivate von atrialnatriurethischem Faktor (ANF). |
CA2129036A1 (fr) * | 1992-02-06 | 1993-08-19 | Mallinckrodt Inc. | Ligands propres a ameliorer la cinetique de la formation du colorant metallifere |
US5716596A (en) * | 1992-06-23 | 1998-02-10 | Diatide, Inc. | Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses |
WO1994009128A1 (fr) * | 1992-10-22 | 1994-04-28 | Mallinckrodt Medical, Inc. | Traitement therapeutique permettant d'inhiber la restenose vasculaire |
DE4301871A1 (de) * | 1993-01-13 | 1994-07-14 | Diagnostikforschung Inst | Neue Mittel zur Diagnose von Gefäßerkrankungen |
US5574140A (en) * | 1993-09-03 | 1996-11-12 | Resolution Pharmaceutical Inc. | Hydrazino-type N2 S2 chelators |
DE69530375T2 (de) * | 1994-01-24 | 2004-02-05 | Neorx Corp., Seattle | Radioaktiv-markierte annexine |
DE69515302T2 (de) * | 1994-05-19 | 2000-07-06 | Neorx Corp | Aromatische aminsubstituierte liganden mit verbrückten stickstoff-und schwefeldonatoratomen für bildformung |
-
1995
- 1995-09-21 DE DE1995136783 patent/DE19536783A1/de not_active Withdrawn
-
1996
- 1996-09-19 EP EP96944563A patent/EP0851771A2/fr not_active Withdrawn
- 1996-09-19 CA CA 2232340 patent/CA2232340A1/fr not_active Abandoned
- 1996-09-19 AU AU13005/97A patent/AU1300597A/en not_active Abandoned
- 1996-09-19 WO PCT/DE1996/001824 patent/WO1997010853A2/fr not_active Application Discontinuation
Non-Patent Citations (1)
Title |
---|
See references of WO9710853A3 * |
Also Published As
Publication number | Publication date |
---|---|
WO1997010853A3 (fr) | 1997-08-28 |
WO1997010853A2 (fr) | 1997-03-27 |
CA2232340A1 (fr) | 1997-03-27 |
AU1300597A (en) | 1997-04-09 |
DE19536783A1 (de) | 1997-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0417870B1 (fr) | Chélates pour complexation d'isotopes radioactifs, leurs complexes et leur utilisation en diagnostic et thérapie | |
DE69837038T2 (de) | Tetraaza- oder n2s2-komplexanten, und deren verwendung in der radiodiagnostik oder radiotherapie | |
EP0692976B1 (fr) | Chelateurs bifonctionnels du type xn 1?s 1?o 1? pour isotopes radioactifs, leurs complexes metalliferes et leur utilisation dans le domaine du diagnostic et de la therapie | |
EP0851771A2 (fr) | Agents de formation de chelates de nicotinamide bifonctionnels du type n2s2 pour isotopes radioactifs | |
WO1997010852A2 (fr) | Agents de chelation amidosulfoniques sulfures bifonctionnels du type xsns pour isotopes radioactifs | |
WO1997012636A2 (fr) | Agents de chelation amidosulfoniques sulfures bifonctionnels du type s2ny pour isotopes radioactifs | |
EP0692979A1 (fr) | Agents chelateurs bifonctionnels et leur utilisation dans des compositions radiopharmaceutiques | |
EP0692981B1 (fr) | Agents chelateurs de type xn 1?s 1?x' d'isotopes radioactifs, leur complexes metalliques et leurs utilisations diagnostiques et therapeutiques | |
DE19860289C2 (de) | Neue Chelatoren sowie deren Tricarbonyl-Komplexe mit Technetium und Rhenium | |
EP0692980B1 (fr) | Agents chelateurs de type s3n2 d'isotopes radioactifs, leurs complexes metalliques et leurs utilisations en diagnostique et therapeutique | |
DE4025788C2 (de) | Technetium- und Rhenium-Komplexe, Verfahren zu ihrer Herstellung sowie deren Verwendung in Diagnostik und Therapie | |
WO1997012850A2 (fr) | Agents chelateurs bifonctionnels au sulfonamide de type xsny contenant des sulfures pour isotopes radioactifs | |
DE4425781A1 (de) | Technetium-Sulfonamid-Komplexe, deren Verwendung, diese enthaltende pharmazeutische Mittel, sowie Verfahren zur Herstellung der Komplexe und Mittel | |
WO1995012610A1 (fr) | Chelateurs n-alkylpeptidiques, leurs complexes metalliques avec des radionucleides, procedes pour leur preparation et compositions radiopharmaceutiques contenant ces composes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980223 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN |
|
18W | Application withdrawn |
Withdrawal date: 19990607 |